MaxCyte Inc (MXCT)

NASDAQ


Symbol		Exchange		Currency
MXCT	·	NASDAQ	·	USD	Real-time
MYE0	·	TradeGate	·	EUR	Delayed

Currency in USD

1.280

+0.020(+1.59%)

Closed·04/09

After Hours

1.2800.000(0.00%)

·04/09

Fair Value

Unlock Value

Day's Range

1.250

1.300

52 wk Range

0.643

1.865

MXCT Income Statement

Assess the MaxCyte income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the MXCT net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

33.89

44.26

41.29

38.63

33.03

Total Revenues Growth

aa.aa

+29.52%

+30.59%

-6.72%

-6.44%

-14.5%

Cost Of Revenues

aa.aa

3.65

5.1

4.74

7.1

6.22

Gross Profit

aa.aa

30.25

39.16

36.55

31.53

26.8

Gross Profit Growth

aa.aa

+29.25%

+29.48%

-6.68%

-13.73%

-14.98%

Gross Profit Margin %

aa.aa

89.24%

88.48%

88.51%

81.62%

81.16%

Other Operating Expenses, Total

aa.aa

48.44

66.52

84.85

82.56

71.34

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+40.56%	+37.35%	+27.54%	-2.69%	-13.59%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	15.41	19.51	23.82	22.23	20.82
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	31.68	44.48	57.04	56.19	46.29
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-18.19

-27.36

-48.3

-51.03

-44.53

Operating Income Growth

aa.aa

-64.5%

-50.43%

-76.52%

-5.66%

+12.73%

EBIT Margin %

aa.aa

-53.66%

-61.82%

-116.98%

-132.12%

-134.85%

Net Interest Expenses

aa.aa

-0.25

3.92

10.38

10.14

7.27

Net Interest Expenses Growth

aa.aa

+36.88%

+1,678.16%

+164.9%

-2.26%

-28.35%

Interest Expense, Total

aa.aa

-0.4

Interest And Investment Income

aa.aa

0.15

3.92

10.38

10.14

7.27

Other Non Operating Expenses, Total

aa.aa

-0.65

-0.13

EBT, Excl. Unusual Items

aa.aa

-19.08

-23.57

-37.92

-40.89

-37.27

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

-19.08

-23.57

-37.92

-41.06

-44.63

EBT, Incl. Unusual Items Growth

aa.aa

-61.49%

-23.52%

-60.89%

-8.26%

-8.71%

EBT, Incl. Unusual Items Margin

aa.aa

-56.3%

-53.25%

-91.85%

-106.29%

-135.14%

Income Tax Expense

aa.aa

Net Income to Company

aa.aa

-19.08

-23.57

-37.92

-41.06

-44.63

Minority Interest

aa.aa

Net Income

aa.aa

-19.08

-23.57

-37.92

-41.06

-44.63

Net Income Growth

aa.aa

-61.49%

-23.52%

-60.89%

-8.26%

-8.71%

Net Income Margin %

aa.aa

-56.3%

-53.25%

-91.85%

-106.29%

-135.14%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-19.08

-23.57

-37.92

-41.06

-44.63

Basic EPS - Continuing Operations

aa.aa

-0.21

-0.23

-0.37

-0.39

-0.42

Basic EPS - Continuing Operations Growth

aa.aa

-23.79%

-10.06%

-58.45%

-6.63%

-7.1%

Diluted EPS - Continuing Operations

aa.aa

-0.21

-0.23

-0.37

-0.39

-0.42

Diluted EPS - Continuing Operations Growth

aa.aa

-23.79%

-10.06%

-58.45%

-6.63%

-7.1%

Basic Weighted Average Shares Outstanding

aa.aa

90.62

101.7

103.27

104.85

106.43

Diluted Weighted Average Shares Outstanding

aa.aa

90.62

101.7

103.27

104.85

106.43

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-16.76

-24.66

-44.13

-46.72

-40.22

EBITDA Growth

aa.aa

-67.5%

-47.11%

-78.92%

-5.87%

+13.9%

EBITDA Margin %

aa.aa

-49.46%

-55.72%

-106.88%

-120.95%

-121.79%

EBIT

aa.aa

-18.19

-27.36

-48.3

-51.03

-44.53

* In Millions of USD (except for per share items)

FAQ

What was MaxCyte’s revenue at year end?

At the end of the last reported fiscal year, MaxCyte (MXCT) recorded total revenue of 33.026 million USD.

How much revenue did MaxCyte report in the most recent quarter?

In its most recent quarterly earnings report, MaxCyte posted revenue of 7.271 million USD.

What was MaxCyte’s net income for the year?

For the full year, MaxCyte reported net income of -44.630 million USD.

How much net income did MaxCyte post in the last quarter?

In the most recent quarter, MaxCyte (MXCT) posted net income of -8.874 million USD.

What was MaxCyte’s gross profit for the year?

Gross profit for the year was reported at 26.804 million USD.

How much gross profit did MaxCyte generate last quarter?

MaxCyte recorded gross profit of 5.596 million USD in its latest quarterly report.

What was MaxCyte’s annual operating income?

For the full year, MaxCyte (MXCT) reported operating income of -44.534 million USD.

What was MaxCyte’s operating income last quarter?

Quarterly operating income was -10.232 million USD.

What was MaxCyte’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -9.254 million USD.

What was the quarter-over-quarter change in EBITDA for MaxCyte?

EBITDA changed by -80.109% million USD compared to the last quarter.

What is MaxCyte’s most recent gross profit margin?

The latest reported gross profit margin for MaxCyte (MXCT) is 76.963% million USD.

What is MaxCyte’s most recent net income margin?

Net income margin based on recent financials is -122.046% million USD.

What is MaxCyte’s most recent EBIT margin?

MaxCyte reported an EBIT margin of -140.723% million USD based on current figures.

How did MaxCyte’s revenue change compared to the previous quarter?

Revenue changed by -24.661% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for MaxCyte?

In the latest quarter, gross profit changed by -30.760% million USD from the previous quarter.

S&P/TSX

36,513.80

-119.32

-0.33%

S&P/TSX 60

2,145.93

-8.12

-0.38%

US 30

53,232.10

-453.4

-0.84%

US 500

7,706.90

-40.7

-0.53%

S&P 500 VIX

14.53

+0.21

+1.47%

DAX

26,046.40

+43.08

+0.17%

Dollar Index

99.13

+0.250

+0.25%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	69.78	-1.09%	34.67M
Suncor Energy	93.14	-1.14%	10.13M
Enbridge	69.32	-0.55%	9.89M
Toronto Dominion Bank	168.24	-0.98%	2.88M
RBC	291.48	-0.30%	1.19M
TC Energy	86.53	-0.16%	3.83M
Canadian Imperial Bank	162.75	-0.15%	1.98M

Name	Last	Chg. %	Vol.
Lanebury Growth Capital	0.15	+200.00%	1.00K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
SQID Tech	0.01	+100.00%	326.67K
ePlay Digital	0.010	+100.00%	7.00K
LFNT Resources	0.20	+90.48%	17.50K
World Copper	0.1750	+84.21%	545.59K
Jura Energy	0.095	+72.73%	27.00K

Name	Last	Chg. %	Vol.
Pioneer Media Holdings	0.01	-100.00%	0.00
Global Health Clinics	0.055	-80.00%	500.00
Carson River Ventures	0.04	-50.00%	1.25K
Ramm Pharma	0.01	-50.00%	1.00K
Albert Labs International	0.005	-50.00%	1.00K
Syntheia	0.02	-50.00%	12.65K
Molecule Holdings	0.005	-50.00%	20.11K

Trending Stocks

Name	Last	Chg. %	Vol.
Hut 8	129.430	+6.61%	602.27K
Celestica Inc.	432.45	+1.15%	246.53K
Bombardier Inc	315.120	+3.56%	271.25K
Canadian Imperial Bank	162.75	-0.15%	1.98M
Keel Infra	4.81	+3.89%	3.68M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaaa	33.12	+52.97%	50.66
Aaaaaa Aaaaaaaaaa	7.76	+50.81%	11.70
Aaaaaaaaa	9.06	+50.49%	13.63
A Aa	102.02	+46.55%	149.51
Aaaaa Aaaaaaaaaaa	16.31	+46.08%	23.83
A Aaaaaaaaaa	125.26	+44.07%	180.46
Aaaaaaaaaaaaaa	5.37	+43.97%	7.73

Name	Last	Upside	Fair Value
Aaaaaaaaaaaa	33.12	+52.97%	50.66
Aaaaaa Aaaaaaaaaa	7.76	+50.81%	11.70
Aaaaaaaaa	9.06	+50.49%	13.63
A Aa	102.02	+46.55%	149.51
Aaaaa Aaaaaaaaaaa	16.31	+46.08%	23.83
A Aaaaaaaaaa	125.26	+44.07%	180.46
Aaaaaaaaaaaaaa	5.37	+43.97%	7.73

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

MaxCyte Inc (MXCT)

MXCT Income Statement

FAQ

What was MaxCyte’s revenue at year end?

How much revenue did MaxCyte report in the most recent quarter?

What was MaxCyte’s net income for the year?

How much net income did MaxCyte post in the last quarter?

What was MaxCyte’s gross profit for the year?

How much gross profit did MaxCyte generate last quarter?

What was MaxCyte’s annual operating income?

What was MaxCyte’s operating income last quarter?

What was MaxCyte’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for MaxCyte?

What is MaxCyte’s most recent gross profit margin?

What is MaxCyte’s most recent net income margin?

What is MaxCyte’s most recent EBIT margin?

How did MaxCyte’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for MaxCyte?

Trending Stocks